UNSPSC 51434206: Vincamine

This classification denotes a cns stimulant with the molecular formula C21H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 996XVD0JHT, chemically known as methyl (3alpha,14alpha,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylate but generally known as vincamine, which bears US NIH Compound Identifier 5668. European Medicines Agency schedules Vincamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00054MIG.

UNSPSC 51434206 Vincamine, a Commodity code, encompasses emergency and critical-care medications that state and local governments procure for fire rescue services, emergency medical services, and multi-state pharmacy benefit programs. Recent activity shows state and local buyers acquiring advanced life support medications including specific formulations of vasopressors, sympathomimetics, and cardiac agents needed for emergency response and pre-hospital care, as well as generic pharmaceuticals and over-the-counter products distributed through cooperative purchasing vehicles to state agencies and participating jurisdictions.

State procurement offices, city purchasing departments, and multi-state cooperative purchasing alliances are the primary issuing bodies. The City of Tampa's Purchasing Department solicited emergency medications for Tampa Fire Rescue via IFB (Bid No. 26-P-00188, due April 8, 2026), with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered market set-aside of 5 percent discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota's Department of Administration, issued an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) serving participating state and local government facilities in Minnesota and Oregon, with pricing weighted at 75 percent and contract term of two years from July 1, 2026. The Texas Health and Human Services Commission issued a Request for Information (RFI No. HHS0017013, April 3, 2026) exploring direct-to-manufacturer pharmacy initiatives. Activity clusters in Florida and the upper Midwest, with Texas exploring program expansion. Vendors should anticipate firm pricing that includes freight, 365-day defect warranties, nine-month minimum shelf life requirements from receipt, OSHA Safety Data Sheets compliance, and in cooperative environments, cGMP and Drug Supply Chain Security Act certification plus substantial commercial general and professional liability insurance.